BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34713899)

  • 1. Clinical Outcomes of Diffuse Sclerosing Variant Papillary Thyroid Carcinoma in Pediatric Patients.
    Brady C; Manning SC; Rudzinski E; Paulson V; Wang X; Liu YJ; Parikh SR; Bonilla-Velez J; Hawkins DS; Dahl J
    Laryngoscope; 2022 May; 132(5):1132-1138. PubMed ID: 34713899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse intrathyroidal dissemination of papillary thyroid carcinoma with no stromal fibrosis at presentation: A pattern of aggressive differentiated thyroid carcinoma.
    Fang H; Si Y; Wang C; Gong Q; Liu C; Wang S
    Pathol Res Pract; 2021 Aug; 224():153510. PubMed ID: 34329840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.
    Akaishi J; Sugino K; Kameyama K; Masaki C; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Shimizu K; Ito K
    World J Surg; 2015 Jul; 39(7):1728-35. PubMed ID: 25743484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis.
    Crayton H; Wu K; Leong D; Bhimani N; Gild M; Glover A
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36952650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.
    Viola D; Giani C; Mazzeo S; Ugolini C; Ciampi R; Molinaro E; Agate L; Borrelli N; Chella A; Fontanini G; Basolo F; Elisei R
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3091-3096. PubMed ID: 28911147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
    Feng J; Shen F; Cai W; Gan X; Deng X; Xu B
    Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.
    Lam AK; Lo CY
    Ann Surg Oncol; 2006 Feb; 13(2):176-81. PubMed ID: 16411146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
    Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
    Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Associated With Aggressive Histopathological Features and a Poor Outcome: Results of a Large Multicentric Study.
    Chereau N; Giudicelli X; Pattou F; Lifante JC; Triponez F; Mirallié E; Goudet P; Brunaud L; Trésallet C; Tissier F; Leenhardt L; du Montcel ST; Menegaux F
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4603-4610. PubMed ID: 27626975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.
    Thompson LD; Wieneke JA; Heffess CS
    Endocr Pathol; 2005; 16(4):331-48. PubMed ID: 16627920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Management of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Experience in 25 Patients.
    Spinelli C; Strambi S; Bakkar S; Nosiglia A; Elia G; Bertocchini A; Calani C; Leoni M; Morganti R; Materazzi G
    World J Surg; 2020 Jan; 44(1):155-162. PubMed ID: 31605177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Related to a Poor Outcome: A Comparison Study Using Propensity Score Matching.
    Yang L; Zhao M; Xiao L; Li L; Dong P
    Endocr Pract; 2023 Oct; 29(10):779-786. PubMed ID: 37169176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.
    Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS
    Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathologic and Prognostic Features of Pediatric Follicular Cell-derived Thyroid Carcinomas: A Retrospective Study of 222 Patients.
    Saliba M; Alzumaili BA; Katabi N; Dogan S; Tuttle RM; Zoltan A; Pandit-Taskar N; Xu B; Ghossein RA
    Am J Surg Pathol; 2022 Dec; 46(12):1659-1669. PubMed ID: 36040037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods.
    Russo M; Malandrino P; Moleti M; Vermiglio F; Violi MA; Marturano I; Minaldi E; Vigneri R; Pellegriti G; Regalbuto C
    J Endocrinol Invest; 2017 Nov; 40(11):1235-1241. PubMed ID: 28528434
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.
    Malandrino P; Russo M; Regalbuto C; Pellegriti G; Moleti M; Caff A; Squatrito S; Vigneri R
    Thyroid; 2016 Sep; 26(9):1285-92. PubMed ID: 27349273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.
    Kim M; Cho SW; Park YJ; Ahn HY; Kim HS; Suh YJ; Choi D; Kim BK; Yang GE; Park IS; Yi KH; Jung CK; Kim BH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):619-627. PubMed ID: 34107674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.